pirenzepine has been researched along with Psoriasis in 1 studies
Pirenzepine: An antimuscarinic agent that inhibits gastric secretion at lower doses than are required to affect gastrointestinal motility, salivary, central nervous system, cardiovascular, ocular, and urinary function. It promotes the healing of duodenal ulcers and due to its cytoprotective action is beneficial in the prevention of duodenal ulcer recurrence. It also potentiates the effect of other antiulcer agents such as CIMETIDINE and RANITIDINE. It is generally well tolerated by patients.
Psoriasis: A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ascari-Raccagni, A | 1 |
| Baldari, U | 1 |
| Rossi, E | 1 |
| Alessandrini, F | 1 |
1 other study available for pirenzepine and Psoriasis
| Article | Year |
|---|---|
Exacerbation of chronic large plaque psoriasis associated with Olanzepine therapy.
Topics: Antipsychotic Agents; Benzodiazepines; Female; Humans; Middle Aged; Olanzapine; Pirenzepine; Psorias | 2000 |